In Tuesday's Blitz Daily, we take a look at Boston-based biotech firm Moderna as top vaccine-makers report earnings.
November isn’t all turkey and over-spiced lattes... It’s also when many big biotech firms drop their quarterly reports and schedule their investor days. Tuesday saw a monster earnings report from Pfizer, crushing estimates and year-over-year comparisons on the back of record-breaking revenue from its coronavirus vaccine.
The news sent the biotech bulls on a buying frenzy, lifting shares of almost every company across the industry as they charged up and down the options chains.
One of Tuesday’s biggest targets was rival vaccine-maker Moderna, whose shares jumped over 3.5% following the report.
And there’s more where that came from. I have two more biotech trades that got a shot in the arm Tuesday...
Every single month, the big hitters on Wall Street tip off what stocks they’re going to pile into…
I’m talking about a signal as clear as day that’s already hit on month-long paydays like 105%... 201%... and even 423%.
As Joy of the Trade Head Trade Jeff Zananiri is about to show us, once we’ve placed our trades early in the month, the hard part is done because Wall Street takes over and does all the heavy lifting for us…
Disclaimer : The material in this document is for informational purposes based on our proprietary research. It is not an offering, specific recommendation, or a solicitation of an offer to buy or sell any securities mentioned or discussed herein.
Any performance results discussed herein represent past performance, are not a guarantee of future performance, and are not indicative of any specific investment.
Due to the timing of information presented, any investment performance reflected within this document may be adjusted after the publication and distribution of this material. There can be no assurance that the future performance of any specific investment, investment strategy, or product made reference to directly or indirectly in this communication will be profitable, be equal to any corresponding indicated historical performance levels or be suitable for your portfolio. Any investment results set forth in this document are not net of expenses and execution costs, nor do they account for other relevant trading or investment fees. Please visit wealthpress.com/terms for our full Terms and Conditions.
0 Response to "Biotech Bulls Blow Up the Tape Tuesday on the Heels of Pfizer Earnings"
Post a Comment